Square closed my peptide store — what to do next
- A Square closure on a peptide store is a policy decision, not a negotiation, so do not waste the first day arguing with support.
- Export everything, file representment on open disputes, and confirm your MATCH status before you apply anywhere new.
- Square and Stripe share the same peptide exclusion, so the rebuild path is a specialist ISO on Authorize.net or NMI, not another mainstream gateway.
On this page
The notification hit your phone during a Tuesday lunch rush: account deactivated, balance on hold, a generic line about prohibited goods. Your peptide store had been taking Square payments for eight months and now the terminal is dead and a chunk of your money is frozen for up to 90 days. Square does not do peptides, the closure is final, and arguing with chat support will burn a day you cannot spare. This playbook is the next 48 hours, written by people who have walked operators through this exact morning more times than we can count. It is not a pitch. We will tell you where multiflow fits and, more often, where a direct rebuild at a specialist ISO is the right move.
First 6 hours: protect your money and your record
Do not open another Square account
Your reflex will be a new Square account under a different entity so the terminal comes back today. Do not. Square links accounts by principal, bank details, device, IP, and card data, and a second account opened in a panic gets closed as a linked account within days. Now you have two Square terminations to explain to the next acquirer instead of one, and every closure compounds.
Export everything before access tightens
Pull your full transaction history, dispute list, customer list, payout history, and refund history out of the Square dashboard now. Square can restrict dashboard access during a deactivation review, and you will need this data for representment and for the next underwriter. Do it first, before anything else.
Do not refund-and-beg to dodge disputes
Refunding customers in bulk to head off chargebacks does not help and can look like you are scrubbing a problem. The acquirer already sees the pattern. Handle disputes through representment, not through panic refunds.
Hours 6 to 24: read the closure correctly
Square closures come in two flavors and the difference drives everything:
- Deactivation with funds release. Account closed, no more processing, but your balance releases on the standard schedule, often up to 90 days. Annoying, recoverable.
- Deactivation with extended hold for cause. Closed, balance held the full window, and possibly a report to the MATCH list. This is the serious one.
Read the exact wording. Language about prohibited or restricted goods is a policy closure. Language about excessive disputes or risk points at your chargeback ratio, which the next acquirer will also scrutinize. Screenshot the notice; you will need it.
Hours 24 to 48: start the rebuild the right way
Check MATCH before you apply anywhere
If the Square closure generated a MATCH entry, applying to a new acquirer blind walks you into a decline you could have seen coming. MATCH is run by Mastercard, retains entries for five years, and uses 14 reason codes. You cannot query it yourself, but an ISO partner checks it during intake. Confirm your status first. If you are on MATCH, read our MATCH escape playbook before doing anything else.
Do not just move to Stripe
Stripe is the most common wrong next step after a Square closure, because Stripe excludes peptides on the same acceptable use grounds Square does. You will get a few weeks of processing and then the identical freeze, now with two terminations on your record. See the Stripe for peptides comparison for why the policies track each other.
File representment on every open dispute
Open chargebacks still need evidence even on a closed account. Upload tracking, delivery confirmation, signed terms, and customer messages per dispute. Representment wins lower the ratio the next acquirer reads, and a clean representment file is part of the story you tell at intake.
The actual rebuild path
For a peptide store, the rebuild is a peptide-friendly acquirer behind a real gateway, not another mainstream processor. The common stack:
| Component | Typical choice | Note |
|---|---|---|
| Gateway | Authorize.net or NMI | Vaults cards, handles recurring |
| Acquirer (single brand) | EasyPayDirect, Durango, Soar | 3.5-4.5% effective |
| Post-MATCH option | High Risk Pay | 4.5-5.5%, heavier reserve |
| Reserve | 10-15% rolling | 180-day hold, year one |
| Underwriting time | 5-10 business days | Bring 3 months of statements |
Verify the acquirer actually approves peptides, and ask the exact chargeback ratio at which they will pause you. Some reserve at 0.5%, others tolerate up to 1.2%. Match your offer structure to their threshold.
Getting your held funds back
The frozen balance is the part that hurts day to day, and the recovery timeline depends entirely on which closure type you got. For a standard deactivation, Square releases the balance on its normal payout schedule, which can stretch toward 90 days from your last transaction while any open disputes settle. For a for-cause hold, the money stays put the full window and you have little leverage to speed it up.
What you can do: keep the dispute queue clean, because each open chargeback is a reason for Square to hold longer. Respond to any verification request quickly and in writing. Do not file a chargeback against Square through your own bank to claw the balance back; that reads as exactly the risk behavior that justifies the hold. Track the exact amount owed against your exported payout history so you can reconcile when the release lands. Treat the held funds as cash you will get, eventually, and plan the next 60 days of operations as if you will not.
What to tell the next underwriter about the closure
A Square closure on your record is not disqualifying. Hiding it is. The next acquirer will ask why you left your last processor, and a peptide-experienced ISO already knows Square does not allow the vertical, so the honest answer is the easy one: Square closed the account on policy grounds because peptides are excluded under their acceptable use terms.
Bring the story they want to hear at intake:
- The closure notice itself, showing prohibited-goods language rather than a fraud or excessive-dispute code.
- Three months of statements or your exported transaction history, so they can see your real volume and ticket size.
- Your chargeback ratio at closure, ideally under the 0.9% Visa and 1.0% Mastercard lines, with representment wins documented.
- The website fixes you have made: clear labels, research-use framing, an FDA-not-evaluated disclaimer where claims appear, and a findable refund policy.
An operator who walks in with that file underwrites faster and at a better rate than one who is vague about why the last account closed. Underwriters reward operators who already understand their own risk.
The first 30 days on the new account
Surviving the rebuild is not just getting approved; it is not getting closed again. The first 30 days on a new peptide account set your reserve and rate for the next year, so run them carefully.
- Do not dump your old volume on day one. Ramp processing over the first week so the acquirer sees a steady curve, not a spike that reads as a velocity event.
- Set the descriptor before the first charge. The statement should read as your peptide brand, not your LLC, so customers recognize it and do not dispute.
- Watch the dispute queue daily. A single early chargeback on a fresh account weighs heavier than the same dispute on a seasoned one.
- Hold aggressive funnels. Skip the flash sales and affiliate pushes until you have 60 to 90 days of clean history. First impressions with an acquirer are expensive to undo.
There is a reason this discipline matters more on a rebuild than on a first launch. The new acquirer already knows you had an account closed, so they are watching the first cycle harder than they would a clean first-timer. A quiet, steady first 30 days tells them the closure was a Square policy line, not a risk problem you carry with you. A spike, an early dispute cluster, or a descriptor mismatch tells them the opposite, and a second closure inside a year is the pattern that starts pushing you toward the MATCH list and the post-MATCH rate tier. Boring is the goal here.
When the parent-account move makes sense
If the Square store was one of several peptide brands you run, the closure is a fork in the road. Rebuild as separate merchant accounts and you carry separate freeze risks and separate underwriting cycles for every brand. Rebuild under one parent account with per-brand descriptors and you concentrate risk but simplify operations. multiflow orchestrates the parent-account model on top of Authorize.net or NMI. We do not claim it fits every operator, and a single-brand store is genuinely better off at a specialist ISO. But if you run three or more peptide brands, it is worth evaluating while the closure is fresh. See the peptide operator page.
What never to do
- Do not open an account under a friend or family member to dodge MATCH. That is factoring, it is fraud, and it MATCH-lists everyone involved.
- Do not misrepresent peptides as generic supplements on the new application. Underwriters read your website and catch it within days.
- Do not stay down. Route high-value orders to ACH or wire while underwriting runs, but keep the business breathing.
What to do right now
Export the data. File representment on open disputes. Confirm your MATCH status through an ISO. Then line up a peptide-friendly acquirer and a gateway, and budget 5 to 10 business days for underwriting. The operators who rebuild with clean representment and a per-brand descriptor structure usually do not run this playbook twice.
If you want a 20-minute read on whether a parent account beats a direct rebuild for your portfolio, send us the application. Twelve questions, no hard pull, and an honest answer inside 48 hours, including pointing you to a specialist ISO if that is the better fit.